Drug Profile
OPC 39436
Alternative Names: OPC39436Latest Information Update: 28 Aug 2018
Price :
$50
*
At a glance
- Originator Otsuka Pharmaceutical
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Aug 2018 No recent reports of development identified for phase-I development in Undefined(In the elderly, In volunteers) in Japan (PO)
- 01 Dec 2016 Otsuka Pharmaceutical completes a phase I trial in the elderly volunteers in Japan (JapicCTI-152980)